Ischemic Cardiomyopathy
Links shared publicly online about this topic
Congestive Cardiac Failure: Ischemic Cardiomyopathy | VEOMED
veomed.com — “Congestive Cardiac Failure: Ischemic Cardiomyopathy | VEOMED” View full resource at veomed.com
Most Recently Shared on January 22, 2010 at 10:10 pm By:
Congestive Cardiac Failure: Ischemic Cardiomyopathy by Emily Hersh-Burdick and Elizabeth Horvitz http://ow.ly/Zgxp
Surgical Ventricular Reconstruction: A Viable Therapy for Ischemic Cardiomyopathy? | VEOMED
veomed.com — “Surgical Ventricular Reconstruction: A Viable Therapy for Ischemic Cardiomyopathy? | VEOMED” View full resource at veomed.com
Most Recently Shared on September 9, 2010 at 11:23 am By:
Surgical Ventricular Reconstruction: A Viable Therapy for Ischemic Cardiomyopathy?, Ulrich Jorde, MD, Columbia Uni.., http://ow.ly/2BDN6
Symposier - STICH Study: medical therapy with or without CABG in patients with Ischemic Cardiomyopathy.
symposier.com — “Uploaded and shared in Youtube by: ACCinTouch --" Dr. Peter Block and Dr. Eric Velazquez discuss medical therapy with or without CABG in patients with Ischemic Cardiomyopathy.” View full resource at symposier.com
Most Recently Shared on April 6, 2011 at 12:38 am By:
Symposier Cardiology Cardiology and Health Business
STICH Study: medical therapy with or without CABG in patients with Ischemic Cardiomyopathy. http://bit.ly/hH4xA1
Medical News: ASE: Intervention Tops Medication for Ischemic Cardiomyopathy - in Meeting Coverage, ASE from MedPage Today
medpagetoday.com — “WASHINGTON -- Patients with ischemic cardiomyopathy fared better with revascularization than with medical therapy in a propensity-score analysis presented here.” View full resource at medpagetoday.com
Most Recently Shared on June 10, 2009 at 3:33 pm By:
CLINICAL TRIALS• ASE: Intervention Tops Medication for Ischemic Cardiomyopathy (CME/CE) http://tinyurl.com/m6d63g
Cardiology Medical News about Cardiomyopathies
mdlinx.com — “Quantity of viable myocardium required to improve survival with revascularization in patients with ischemic cardiomyopathy: A meta-analysis” View full resource at mdlinx.com
Most Recently Shared on April 16, 2010 at 8:45 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Quantity of viable myocardium required to improve survival with revascularization in patients with ... http://bit.ly/b8md8O #cardio #mdlinx
Cardiology Medical News about Cardiomyopathies
mdlinx.com — “Differential Effect of Biventricular and Right Ventricular DDD Pacing on Coronary Flow Reserve in Patients With Ischemic Cardiomyopathy” View full resource at mdlinx.com
Most Recently Shared on June 22, 2010 at 12:42 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Differential Effect of Biventricular and Right Ventricular DDD Pacing on Coronary Flow Reserve in P... http://bit.ly/bDaihV #cardio #mdlinx
Endocrinology News - Effectiveness of cardiac resynchronization therapy in diabetic patients with ischemic and nonischemic cardiomyopathy |3968855
mdlinx.com — “Endocrinology Medical Article: Effectiveness of cardiac resynchronization therapy in diabetic patients with ischemic and nonischemic cardiomyopathy” View full resource at mdlinx.com
Most Recently Shared on March 16, 2012 at 1:32 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Effectiveness of cardiac resynchronization therapy in diabetic patients with ischemic and nonischemic card... http://t.co/IRSXHaee #endo
Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial : The Lancet
thelancet.com — “Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. By - Prof Roberto Bolli MD, Atul R Chugh MD, Domenico D'Amario MD, John H Lough...” View full resource at thelancet.com
Most Recently Shared on November 14, 2011 at 2:10 pm By:
First-in-man study shows cardiac stem cells show promise for treating heart failure caused by ischaemic heart disease http://t.co/jwklyA2h
A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary preventi
eurheartj.oxfordjournals.org — “A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study " Eur Heart J” View full resource at eurheartj.oxfordjournals.org
Most Recently Shared on November 25, 2009 at 10:50 am By:
European Cardiology Cardiology and Medical Society
RELEVANT study on a simplified, biventricular defibrillator... http://tinyurl.com/ylbss3x
Heart Transplantation: eMedicine Transplantation
emedicine.medscape.com — “Overview: Cardiac transplantation is a widely accepted therapy for the treatment of end-stage congestive heart failure. Most candidates for cardiac transplantation have not been helped by conventional medical therapy and are excluded from other surgical options because of ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 25, 2010 at 3:55 am By:
Cardiac transplantation is a widely accepted therapy for the treatment of end-stage congestive heart failure. http://bit.ly/aRhpxe
ICDs Need To Be Flexible And Durable Enough For Patients Living Longer
medicalnewstoday.com — “Most patients with ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) who have an implantable cardioverter-defibrillator (ICD) now live more than seven years and those ICD patients wit” View full resource at medicalnewstoday.com
Most Recently Shared on April 5, 2011 at 10:58 am By:
Drugs and Devices OW OW Health
ICDs Need To Be Flexible And Durable Enough For Patients Living Longer: Most patients with ischemic c... http://bit.ly/gvUxM6 #MedDevice
Cytokinetics To Present Phase IIa Clinical Trials Data On Omecamtiv Mecarbil At The European Society Of Cardiology Congress 2009
medicalnewstoday.com — “Cytokinetics, incorporated (nasdaq: cytk) announced that data relating to two phase iia clinical trials evaluating omecamtiv mecarbil (formerly ck-1827452), one in stable heart failure patients an” View full resource at medicalnewstoday.com
Most Recently Shared on August 25, 2009 at 1:28 pm By:
MedicalNewsToday: Cytokinetics To Present Phase IIa Clinical Trials Data On Omecamtiv Mecarbil http://bit.ly/7ewXA Full http://bit.ly/OYWwF
Aged, Damaged Hearts Yield Stem Cells That Could Treat Heart Failure
medicalnewstoday.com — “Cardiac stem cells - even in elderly and sick patients - could generate new heart muscle and vessel tissue and be used to treat heart failure, according to research presented at the American Heart” View full resource at medicalnewstoday.com
Most Recently Shared on November 18, 2010 at 3:37 pm By:
Aged, Damaged Hearts Yield Stem Cells That Could Treat Heart Failure Cardiac stem cells - even in elderly and sick pati.. http://dld.bz/6Zwn
Cardiology Medical News about Coronary Artery Bypass
mdlinx.com — “Mortality Reduction With (beta)-Blockers in Ischemic Cardiomyopathy Patients Undergoing Coronary Artery Bypass Grafting” View full resource at mdlinx.com
Most Recently Shared on March 23, 2010 at 2:26 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Mortality Reduction With (beta)-Blockers in Ischemic Cardiomyopathy Patients Undergoing Coronary Ar... http://bit.ly/cYpJR0 #cardio #mdlinx
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
VeoMed Team
VeoMed is an Open Access Medical Education Resource.
-
VeoMed Team
VeoMed is an Open Access Medical Education Resource.
-
Symposier Cardiology
Symposier.com, the technological platform that will allow you (and your colleagues) to share medical information, and much more with medicine professionals.
Advertisement
